148 related articles for article (PubMed ID: 15911618)
1. Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator.
Fredriksson L; Ehnman M; Fieber C; Eriksson U
J Biol Chem; 2005 Jul; 280(29):26856-62. PubMed ID: 15911618
[TBL] [Abstract][Full Text] [Related]
2. Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.
Riehle KJ; Johnson MM; Johansson F; Bauer RL; Hayes BJ; Gilbertson DG; Haran AC; Fausto N; Campbell JS
Biochim Biophys Acta; 2014 Feb; 1842(2):318-25. PubMed ID: 24269585
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator is a potent activator of PDGF-CC.
Fredriksson L; Li H; Fieber C; Li X; Eriksson U
EMBO J; 2004 Oct; 23(19):3793-802. PubMed ID: 15372073
[TBL] [Abstract][Full Text] [Related]
4. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
[TBL] [Abstract][Full Text] [Related]
5. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.
Su EJ; Fredriksson L; Geyer M; Folestad E; Cale J; Andrae J; Gao Y; Pietras K; Mann K; Yepes M; Strickland DK; Betsholtz C; Eriksson U; Lawrence DA
Nat Med; 2008 Jul; 14(7):731-7. PubMed ID: 18568034
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.
Ustach CV; Kim HR
Mol Cell Biol; 2005 Jul; 25(14):6279-88. PubMed ID: 15988036
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression.
Hurst NJ; Najy AJ; Ustach CV; Movilla L; Kim HR
Biochem J; 2012 Feb; 441(3):909-18. PubMed ID: 22035541
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation.
Bossé Y; Thompson C; Stankova J; Rola-Pleszczynski M
Am J Respir Cell Mol Biol; 2006 Jun; 34(6):746-53. PubMed ID: 16439802
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor.
Gilbertson DG; Duff ME; West JW; Kelly JD; Sheppard PO; Hofstrand PD; Gao Z; Shoemaker K; Bukowski TR; Moore M; Feldhaus AL; Humes JM; Palmer TE; Hart CE
J Biol Chem; 2001 Jul; 276(29):27406-14. PubMed ID: 11297552
[TBL] [Abstract][Full Text] [Related]
10. Platelet derived growth factor-CC isoform is associated with hemorrhagic transformation in ischemic stroke patients treated with tissue plasminogen activator.
Rodríguez-González R; Blanco M; Rodríguez-Yáñez M; Moldes O; Castillo J; Sobrino T
Atherosclerosis; 2013 Jan; 226(1):165-71. PubMed ID: 23218119
[TBL] [Abstract][Full Text] [Related]
11. The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth.
Ehnman M; Li H; Fredriksson L; Pietras K; Eriksson U
Oncogene; 2009 Jan; 28(4):534-44. PubMed ID: 18997817
[TBL] [Abstract][Full Text] [Related]
12. Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy.
Lei H; Velez G; Hovland P; Hirose T; Kazlauskas A
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):42-8. PubMed ID: 18172073
[TBL] [Abstract][Full Text] [Related]
13. PDGF-D expression is down-regulated by TGFβ in fibroblasts.
Charni Chaabane S; Coomans de Brachène A; Essaghir A; Velghe A; Lo Re S; Stockis J; Lucas S; Khachigian LM; Huaux F; Demoulin JB
PLoS One; 2014; 9(10):e108656. PubMed ID: 25280005
[TBL] [Abstract][Full Text] [Related]
14. A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer.
Ustach CV; Huang W; Conley-LaComb MK; Lin CY; Che M; Abrams J; Kim HR
Cancer Res; 2010 Dec; 70(23):9631-40. PubMed ID: 21098708
[TBL] [Abstract][Full Text] [Related]
15. PDGF-D Prodomain Differentially Inhibits the Biological Activities of PDGF-D and PDGF-B.
Li L; Wu D; Qin X; Mi LZ
J Mol Biol; 2022 Aug; 434(16):167709. PubMed ID: 35777468
[TBL] [Abstract][Full Text] [Related]
16. Characterization of platelet-derived growth factor-C (PDGF-C): expression in normal and tumor cells, biological activity and chromosomal localization.
Dijkmans J; Xu J; Masure S; Dhanaraj S; Gosiewska A; Geesin J; Sprengel J; Harris S; Verhasselt P; Gordon R; Yon J
Int J Biochem Cell Biol; 2002 Apr; 34(4):414-26. PubMed ID: 11854040
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta 1 downregulates the platelet-derived growth factor alpha-receptor subtype on human lung fibroblasts in vitro.
Bonner JC; Badgett A; Lindroos PM; Osornio-Vargas AR
Am J Respir Cell Mol Biol; 1995 Oct; 13(4):496-505. PubMed ID: 7546780
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of SCDGF-B, a novel growth factor homologous to SCDGF/PDGF-C/fallotein.
Hamada T; Ui-Tei K; Imaki J; Miyata Y
Biochem Biophys Res Commun; 2001 Jan; 280(3):733-7. PubMed ID: 11162582
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of human skin fibroblast chemotaxis to platelet-derived growth factor A-chain homodimer by transforming growth factor-beta1.
Soma Y; Mizoguchi M; Yamane K; Yazawa N; Kubo M; Ihn H; Kikuchi K; Tamaki K
Arch Dermatol Res; 2002 Feb; 293(12):609-13. PubMed ID: 11875643
[TBL] [Abstract][Full Text] [Related]
20. Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts.
Seikrit C; Henkel C; van Roeyen CR; Bokemeyer D; Eitner F; Martin IV; Boor P; Knüchel R; Meyer HE; Müller-Newen G; Eriksson U; Floege J; Ostendorf T
Nephrol Dial Transplant; 2013 Apr; 28(4):889-900. PubMed ID: 23229927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
